Laurent Créancier
- Molecular Biology top 5%
- Oncology top 2%
- Biotechnology top 1%
- Cancer Research top 5%
- Cardiology and Cardiovascular Medicine top 10%
- Co-authors
- Anne‐Catherine PratsPascual FerraraPascale ChalonA MintyH BonnetAlexandre ValentDaniel CaputXavier Dumont
- Topics
- RNA and protein synthesis mechanisms (8 papers)Cancer-related Molecular Pathways (4 papers)Acute Myeloid Leukemia Research (3 papers)
- Partner nations
- FranceUnited KingdomGermany
In The Last Decade
Laurent Créancier
27 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Molecular Biology 2.3k
- Oncology 1.3k
- Biotechnology 488
- Cancer Research 388
- Cardiology and Cardiovascular Medicine 255
Countries citing papers authored by Laurent Créancier
This map shows the geographic impact of Laurent Créancier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Créancier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Créancier more than expected).
Fields of papers citing papers by Laurent Créancier
This network shows the impact of papers produced by Laurent Créancier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Créancier. The network helps show where Laurent Créancier may publish in the future.
Co-authorship network of co-authors of Laurent Créancier
This figure shows the co-authorship network connecting the top 25 collaborators of Laurent Créancier. A scholar is included among the top collaborators of Laurent Créancier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent Créancier. Laurent Créancier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 71 | |
| 3 | 1 | |
| 4 | 30 | |
| 5 | 6 | |
| 6 | 21 | |
| 7 | 10 | |
| 8 | 141 | |
| 9 | 55 | |
| 10 | 37 | |
| 11 | 21 | |
| 12 | 54 | |
| 13 | 144 | |
| 14 | 97 | |
| 15 | 46 | |
| 16 | 48 | |
| 17 | 84 | |
| 18 | Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancersbreakdown → | 1404 |
| 19 | 74 | |
| 20 | 38 |
About Laurent Créancier
Laurent Créancier is a scholar working on Hematology, Cancer Research and Oncology, having authored 28 papers that have together received 3.0k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (8 papers), Cancer-related Molecular Pathways (4 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Biotechnology (488 citations), Oncology (1.3k citations) and Molecular Biology (2.3k citations). Laurent Créancier has collaborated with scholars based in France, United Kingdom and Germany. Frequent co-authors include Anne‐Catherine Prats, Pascual Ferrara, Pascale Chalon, A Minty, H Bonnet, Alexandre Valent, Daniel Caput, Xavier Dumont, Annie Yang and Jean-Michel Lélias. Their work appears in journals such as Cell, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.